These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9294231)

  • 1. Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor.
    Weaver CE; Marek P; Park-Chung M; Tam SW; Farb DH
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10450-4. PubMed ID: 9294231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic structural modifications of neurosteroid pregnanolone sulfate: Assessment of neuroprotective effects in vivo.
    Chvojkova M; Rambousek L; Chodounska H; Kudova E; Vales K
    Eur J Pharmacol; 2020 Aug; 881():173187. PubMed ID: 32446713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3alpha-hydroxy-5beta-pregnan-20-one hemisuccinate.
    Sadri-Vakili G; Johnson DW; Janis GC; Gibbs TT; Pierce RC; Farb DH
    J Neurochem; 2003 Jul; 86(1):92-101. PubMed ID: 12807429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice.
    Budziszewska B; Siwanowicz J; Leśkiewicz M; Jaworska-Feil L; Lasoń W
    Eur Neuropsychopharmacol; 1998 Feb; 8(1):7-12. PubMed ID: 9452934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroactive steroid 3-alpha-ol-5-beta-pregnan-20-one hemisuccinate, a selective NMDA receptor antagonist improves behavioral performance following spinal cord ischemia.
    Lapchak PA
    Brain Res; 2004 Feb; 997(2):152-8. PubMed ID: 14706867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
    Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and behavioural effects of a new steroidal inhibitor of the N-methyl-d-aspartate receptor 3α5β-pregnanolone glutamate.
    Rambousek L; Bubenikova-Valesova V; Kacer P; Syslova K; Kenney J; Holubova K; Najmanova V; Zach P; Svoboda J; Stuchlik A; Chodounska H; Kapras V; Adamusova E; Borovska J; Vyklicky L; Vales K
    Neuropharmacology; 2011; 61(1-2):61-8. PubMed ID: 21354187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
    J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke.
    Yu G; Wu F; Wang ES
    Int J Clin Exp Pathol; 2015; 8(2):1213-25. PubMed ID: 25973006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids.
    Park-Chung M; Wu FS; Purdy RH; Malayev AA; Gibbs TT; Farb DH
    Mol Pharmacol; 1997 Dec; 52(6):1113-23. PubMed ID: 9396781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-methyl-N,N-diethylthiocarbamate sulfoxide elicits neuroprotective effect against N-methyl-D-aspartate receptor-mediated neurotoxicity.
    Ningaraj NS; Chen W; Schloss JV; Faiman MD; Wu JY
    J Biomed Sci; 2001; 8(1):104-13. PubMed ID: 11173983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of the 3α5β-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats.
    Kleteckova L; Tsenov G; Kubova H; Stuchlik A; Vales K
    Neurosci Lett; 2014 Apr; 564():11-5. PubMed ID: 24513236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: behavioural and electrophysiological evidence.
    D'Hooge R; Raes A; Lebrun P; Diltoer M; Van Bogaert PP; Manil J; Colin F; De Deyn PP
    Neuropharmacology; 1996 Apr; 35(4):433-40. PubMed ID: 8793905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
    D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
    Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
    Alex AB; Saunders GW; Dalpé-Charron A; Reilly CA; Wilcox KS
    Neurotoxicology; 2011 Aug; 32(4):392-9. PubMed ID: 21396956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Gastrodin on Hippocampal Neurons after N-Methyl-D-Aspartate Excitotoxicity and Experimental Temporal Lobe Seizures.
    Wong SB; Hung WC; Min MY
    Chin J Physiol; 2016 Jun; 59(3):156-64. PubMed ID: 27188468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors.
    Li L; Yang R; Sun K; Bai Y; Zhang Z; Zhou L; Qi Z; Qi J; Chen L
    Int J Neuropsychopharmacol; 2012 May; 15(4):497-507. PubMed ID: 21557879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
    Molz S; Tharine DC; Decker H; Tasca CI
    Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
    Pringle AK; Self J; Eshak M; Iannotti F
    Eur J Neurosci; 2000 Nov; 12(11):3833-42. PubMed ID: 11069578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.